Interferon Is Superior to Direct Acting Antiviral Therapy in Tertiary Prevention of Early Recurrence of Hepatocellular Carcinoma

The elimination of chronic hepatitis C infection (CHC) by pegylated interferon plus ribavirin (Peg-IFN/RBV) decreases hepatocellular carcinoma (HCC) recurrence rate. However, the tertiary prevention of HCC recurrence by direct acting antiviral agents (DAA) remains controversial. This study aims to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Wei, Jeng, Wen-Juei, Yang, Hwai-I, Chen, Wei-Ting, Hsieh, Yi-Chung, Huang, Chien-Hao, Lin, Chen-Chun, Lin, Chun-Yen, Lin, Shi-Ming, Sheen, I-Shyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016942/
https://www.ncbi.nlm.nih.gov/pubmed/31861706
http://dx.doi.org/10.3390/cancers12010023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016942/
https://www.ncbi.nlm.nih.gov/pubmed/31861706
http://dx.doi.org/10.3390/cancers12010023

Ejemplares similares